In our study, we found that tumor-derived ITGBL1-enriched EVs are directly transferred to lung and liver metastatic niche, and converts fibroblasts and stellate cells to CAFs by binding to TNFAIP3, and activating the NF-κB signaling pathway. The gene discussed is NFKB1; the disease is neoplasm.